Page last updated: 2024-09-05

anidulafungin and Critical Illness

anidulafungin has been researched along with Critical Illness in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (4.55)	29.6817
2010's	17 (77.27)	24.3611
2020's	4 (18.18)	2.80

Authors

Authors	Studies
Apostolidi, S; Apostolopoulou, O; Dimopoulos, G; Dokoumetzidis, A; Kapralos, I; Mainas, E; Meletiadis, J; Neroutsos, E; Sambatakou, H; Siopi, M; Valsami, G	1
Li, Y; Liu, D; Liu, X; Pan, Y	1
Alvarez, ME; Cuenca-Estrella, M; Fortun, J; Gioia, F; Gomez-García de la Pedrosa, E; Gomez-Lopez, A; Martín-Davila, P; Moreno, S	1
Ala-Kokko, TI; Ämmälä, S; Koskenkari, J; Laurila, JJ; Syrjälä, H; Ylipalosaari, P	1
Graf, BM; Gruber, M; Ittner, KP; Kolbinger, P; Roth, G	1
Bellmann, R; Eller, P; Joannidis, M; Lorenz, I; Welte, R	1
Alvarez-Lerma, F; Barceló-Vidal, J; Campillo, N; González-Colominas, E; Grau, S; Hope, W; Horcajada, JP; Luque, S; Masclans, JR; Montero, M; Muñoz-Bermúdez, R; Sorli, L	1
Azanza Perea, JR; García-Montoto Pérez, F; Jerez Gómez-Coronado, V; Pazos Pacheco, C; Pérez Civantos, DV; Robles Marcos, M	1
Baietto, L; Corcione, S; D'Avolio, A; De Rosa, FG; Di Perri, G; Pasero, D; Ranieri, VM	1
Alffenaar, JW; Arends, JP; Kosterink, JG; Rodgers, MG; Uges, DR; van der Werf, TS; van Wanrooy, MJ; Zijlstra, JG	1
Aguilar, G; Azanza, JR; Badenes, R; Belda, FJ; Carbonell, JA; Ferrando, C; Garcia-Marquez, C; Gencheva, G; Gutierrez, A; Marti, FJ; Miñana, A; Navarro, D; Parra, MA; Puig, J; Sadaba, B	1
Alffenaar, JW; Kosterink, JG; Proost, JH; Rodgers, MG; Uges, DR; van der Werf, TS; van Wanrooy, MJ; Zijlstra, JG	1
Akova, M; Bassetti, M; De Waele, JJ; Dimopoulos, G; Kaukonen, KM; Koulenti, D; Lipman, J; Martin, C; Montravers, P; Rello, J; Rhodes, A; Roberts, JA; Sinnollareddy, MG; Starr, T; Wallis, SC	1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Lempers, VJ; Muilwijk, EW; Pickkers, P; Warris, A	1
Groeneveld, AB; Rijnders, BJ; van der Geest, PJ; Vonk, AG	1
Groeneveld, AB; Hunfeld, NG; Ladage, SE; van der Geest, PJ	1
Ammenouche, N; Dupont, H; Jung, B; Massias, L; Montravers, P	1
Borges Sá, M; Garnacho Montero, J	1
Cartier, S; Chambers, R; Kett, DH; Maschio, M; Reboli, AC; Rotstein, C; Tarallo, M	1
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G	1
Auzinger, G; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sá, MB; Sganga, G	1
Damle, B; Kantecki, M; Liu, P; Meersseman, W; Paiva, JA; Ruhnke, M	1

Reviews

3 review(s) available for anidulafungin and Critical Illness

Article	Year
Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6 Topics: Anidulafungin; Antifungal Agents; Area Under Curve; Caspofungin; Critical Illness; Echinocandins; Humans; Invasive Fungal Infections; Micafungin	2020
Impact of special patient populations on the pharmacokinetics of echinocandins. Expert review of anti-infective therapy, 2015, Volume: 13, Issue:6 Topics: Adolescent; Adult; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Child; Critical Illness; Drug Interactions; Echinocandins; Hematologic Diseases; Humans; Infant, Newborn; Kidney; Lipopeptides; Liver; Micafungin; Microbial Sensitivity Tests; Obesity	2015
[Role of anidulafungin in critically ill patients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic	2008

Trials

4 trial(s) available for anidulafungin and Critical Illness

Article	Year
Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study. BMC infectious diseases, 2016, 09-15, Volume: 16 Topics: Anidulafungin; Antifungal Agents; APACHE; Candidiasis, Invasive; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Lipopeptides; Liver; Liver Function Tests; Male; Micafungin; Middle Aged; Regression Analysis; Retrospective Studies; Treatment Outcome	2016
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2012
Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis. International journal of antimicrobial agents, 2012, Volume: 40, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Humans; Incidence; Male; Middle Aged; Survival Analysis; Treatment Outcome	2012
Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4 Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidemia; Candidiasis, Invasive; Critical Illness; Echinocandins; Female; Humans; Male; Middle Aged	2013

Other Studies

15 other study(ies) available for anidulafungin and Critical Illness

Article	Year
Population pharmacokinetics of anidulafungin in ICU patients assessing inter- and intrasubject variability. British journal of clinical pharmacology, 2021, Volume: 87, Issue:3 Topics: Anidulafungin; Anti-Bacterial Agents; Cohort Studies; Critical Illness; Humans; Intensive Care Units; Microbial Sensitivity Tests	2021
Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 101 Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Critical Illness; Echinocandins; Female; Humans; Male; Micafungin; Microbial Sensitivity Tests; Peritonitis; Prospective Studies	2020
Use and outcome of empiric echinocandins in critically ill patients. Acta anaesthesiologica Scandinavica, 2021, Volume: 65, Issue:7 Topics: Adult; Anidulafungin; Antifungal Agents; Critical Illness; Echinocandins; Humans; Middle Aged; Retrospective Studies	2021
Filter Adsorption of Anidulafungin to a Polysulfone-Based Hemofilter During CVVHD In Vitro. Artificial organs, 2018, Volume: 42, Issue:2 Topics: Acute Kidney Injury; Adsorption; Anidulafungin; Antifungal Agents; Candidemia; Critical Illness; Dialysis Solutions; Echinocandins; Humans; Kidney Failure, Chronic; Polymers; Renal Dialysis; Sulfones	2018
Anidulafungin Pharmacokinetics in Ascites Fluid and Pleural Effusion of Critically Ill Patients. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Ascites; Candida; Chromatography, High Pressure Liquid; Critical Illness; Echinocandins; Female; Humans; Male; Middle Aged; Pleural Effusion	2018
Population Pharmacokinetics of Anidulafungin in Critically Ill Patients. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Body Weight; Candida albicans; Candida glabrata; Candidiasis; Critical Illness; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological	2019
Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 86 Topics: Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; APACHE; Area Under Curve; Ascitic Fluid; Candida; Candidiasis; Critical Illness; Echinocandins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Peritonitis; Prospective Studies	2019
Pharmacokinetics of anidulafungin in two critically ill patients with septic shock undergoing CVVH. Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:6 Topics: Aged; Anidulafungin; Antifungal Agents; Area Under Curve; Candidemia; Critical Illness; Echinocandins; Female; Hemofiltration; Humans; Male; Middle Aged; Shock, Septic	2013
Low but sufficient anidulafungin exposure in critically ill patients. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Aged; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Critical Illness; Echinocandins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged	2014
Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Echinocandins; Hemodiafiltration; Humans; Intensive Care Units	2014
Limited-sampling strategies for anidulafungin in critically ill patients. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2 Topics: Adult; Aged; Anidulafungin; Bayes Theorem; Candidiasis, Invasive; Critical Illness; Echinocandins; Female; Humans; Male; Middle Aged; Prospective Studies; Young Adult	2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. Critical care (London, England), 2015, Feb-04, Volume: 19 Topics: Aged; Anidulafungin; Antifungal Agents; Caspofungin; Critical Illness; Drug Monitoring; Echinocandins; Europe; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Middle Aged	2015
Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections. Mycoses, 2016, Volume: 59, Issue:3 Topics: Administration, Intravenous; Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Critical Illness; Echinocandins; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Multivariate Analysis; Retrospective Studies	2016
Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Administration, Intravenous; Aged; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Chromatography, High Pressure Liquid; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Intraabdominal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies	2017
Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients. PharmacoEconomics, 2011, Volume: 29, Issue:8 Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidemia; Candidiasis, Invasive; Clinical Trials, Phase III as Topic; Critical Illness; Double-Blind Method; Drug Costs; Echinocandins; Female; Fluconazole; Health Resources; Hospital Costs; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Randomized Controlled Trials as Topic; Regression Analysis; Retrospective Studies	2011